About
Inga Deakin's Oxford and Cambridge neuroscience training plus experience at a US molecular diagnostics company informs investments in ML-driven healthtech using proprietary data to ease specialist shortages and overloaded workflows.
Invests in
BiotechConsumerDeep TechDigital HealthFintechHardwareHealthtechSaaS
Experience
- Molten VenturesPartnercurrent2020 β presentLondon, England, United Kingdom
- QureightDirectorcurrent2026 β presentCambridge, UK
- DeciphexDirectorcurrent2025 β present
- AnimaDirectorcurrent2023 β present
- IMU BiosciencesDirectorcurrent2023 β present
- OlivaDirectorcurrent2023 β present
- AktiiaDirectorcurrent2021 β presentSwitzerland and USA
- Duke UniversityEntrepreneur In Residence2019 β 2020Raleigh-Durham, North Carolina Area
- Inivata LimitedChief of Staff2017 β 2019Raleigh-Durham, North Carolina Area
- Touchstone InnovationsPrincipal2017 β 2018London, United Kingdom
- PuridifyNon Executive Director2015 β 2017
- PuridifyBoard Observer2014 β 2015London, United Kingdom
- APCINTEX LIMITEDBoard Observer2016 β 2017Cambridge, United Kingdom
- OxularBoard Observer2016 β 2017Oxford, United Kingdom
- Ieso Digital HealthNon Executive Director2015 β 2017Cambridge, United Kingdom
- Ieso Digital HealthBoard Observer2013 β 2015Cambridge, United Kingdom
- Veryan MedicalBoard Observer2014 β 2017
- Imperial InnovationsPrincipal2016
- Imperial InnovationsHealthcare Ventures Associate2013 β 2016London, Cambridge, Oxford
- Imperial InnovationsHealthcare Ventures Analyst2011 β 2013London, Cambridge, Oxford
Education
- University of OxfordDPhil PhD, Neuroscience2005 β 2009
- Duke University - The Fuqua School of BusinessNavigating Healthcare Trends Certificate
- University of OxfordMSc, Neuroscience2004 β 2005
- University of CambridgeBA, Natural Sciences2001 β 2004
- Withington Girls'β SchoolHead Girl
Skills & more
Venture Capital16Lifesciences26Biotechnology26Business Development20Medical Devices7Life Sciences13Technology Transfer36Molecular Biology11Science10Entrepreneurship9Intellectual Property9Business Planning7
+4 more
HealthcareCommercializationMarket AnalysisPharmaceutical IndustryFrom Inga's professional profile.
Same school
Also attended University of Oxford688
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 682 more
Also attended Duke University - The Fuqua School of Business165
David BlivinMANAGING PARTNER at Cottonwood Technology FundVinnie McSweeneyInvestor at OpenView Venture PartnersBrooke BalcomBoard Member at CincyTechChad L. SummeBoard Member at CincyTechMatias BarberoVenture Partner at FJ LabsTracie RotterPartner, Platform at Lux Capital
+ 159 more
Also attended University of Cambridge621
Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures
+ 615 more
Shared employers
Also worked at Deciphex1
Also worked at IMU Biosciences3
Also worked at APCINTEX LIMITED1
Colleagues at Molten Ventures
Alan Duncan
Venture Partner at Molten Ventures
Andrew Zimmermann
Chief Financial Officer at Molten Ventures
Bakhrom Ibragimov
Partner - Head of Molten East at Molten Ventures
Ben Wilkinson
CEO at Molten Ventures
Bindi Karia
Venture Partner at Molten Ventures
Brian Caulfield
Venture Partner at Molten Ventures
Ceyda Sabanci DinΓ§er
Associate at Molten Ventures
Christoph Hornung
Partner at Molten Ventures
Network4
Alan Duncan
Venture Partner at Molten Ventures
Brian Caulfield
Venture Partner at Molten Ventures
Christoph Hornung
Partner at Molten Ventures
David Cummings
Venture Partner at Molten Ventures
Investors connected to Inga in public investor directories β a warm-intro map.









.png)


















